Recombinant CD40 Ligand antibody

Catalog No. ABIN7826071

This Mouse Monoclonal antibody specifically detects CD40 Ligand in FACS and ELISA. It exhibits reactivity toward Mouse.

Quick Overview for Recombinant CD40 Ligand antibody (ABIN7826071)

Target: CD40 Ligand (CD40LG)

Antibody Type: Recombinant Antibody

Reactivity: Mouse

Host: Mouse

Clonality: Monoclonal

Conjugate: This CD40 Ligand antibody is un-conjugated

Application: Flow Cytometry (FACS), ELISA

Grade: In vivo Grade

Clone: MR1

Product Details anti-CD40 Ligand Antibody

Expression System: CHO Cells

Purpose: CD40L recombinant monoclonal antibody, clone MR1 targeting mouse CD40L recombinant protein.

Cross-Reactivity: Mouse

Characteristics: In Vivo Functional Grade Antibodies are optimized for mouse and rat studies, ensuring safety and accuracy in live animal experiments. Each antibody is highly purified and validated by flow cytometry using positive and negative control cell lines. The collection includes mouse-target and human-target antibodies suitable for syngeneic and xenograft tumor models, supporting robust preclinical immunotherapy research

Purification: Protein A purified

Purity: > 95 % by SDS-PAGE under reducing conditions.

Sterility: 0.2 μm filtered

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method.

Immunogen: Mouse CD40L recombinant protein

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: ≥ 3 μg/μL

Buffer: PBS pH 7.4 with no stabilizers or preservatives added

Preservative: Without preservative

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot to avoid repeated freezing and thawing.

Expiry Date: 12 months

Target Details for CD40 Ligand

Target: CD40 Ligand (CD40LG)

Alternative Name: Cd40lg

Background:

Gene description: CD40 ligand

Gene alias: CD154, Cd40l, HIGM1, IGM, IMD3, Ly-62, Ly62, T-BAM, TRAP, Tnfsf5, gp39

Gene ID: 21947

Pathways: NF-kappaB Signaling, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints